Anixa Biosciences ($ANIX) Insider Trading & Smart Money Activity
Anixa Biosciences, Inc. ($ANIX) has 6 insider trades and 1 analyst rating on file. In the last 12 months on the open market, 5 insiders bought ($240.77K) and no insider sold, net +$240.77K.
- Insider buyers (12 mo)
- 5
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$240.77K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 1
ANIX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 2 · $59.99K | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 4 · $180.79K | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ANIX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Catelani MichaelPresident, COO, & CFO | Buy (Open-market buy) | 5.50K sh | $15.62K | +0.7% | — | |||||
| Insider | Amit KumarChief Executive Officer | Buy (Open-market buy) | 7K sh | $19.46K | -0.4% | — | |||||
| Insider | Baskies Arnold MDirector | Buy (Open-market buy) | 5K sh | $13.80K | -0.4% | — | |||||
| Insider | Titterton Lewis H jrDirector | Buy (Open-market buy) | 49.04K sh | $131.91K | +6.5% | — | |||||
| Analyst | D. Boral Capital | Raises to buy | PT $10 | +5.7% | +27.1% | Read | |||||
| Insider | Titterton Lewis JR | Buy (Open-market buy) | 2.84K sh | $7.49K | +5.7% | +27.2% | Read | ||||
| Insider | Amit KumarChief Executive Officer | Buy (Open-market buy) | 21K sh | $52.50K | +12.1% | +23.9% | Read |
1W / 1M / 6M = how ANIX moved from the trade or filing date.
Insider trading in ANIX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Catelani Michael | President, COO, & CFO | 1 | +$15.62K | Sep 30, 2026 | |
| Amit Kumar | Chief Executive Officer | 2 | +$71.96K | Sep 24, 2026 | |
| Baskies Arnold M | Director | 1 | +$13.80K | Sep 24, 2026 | |
| Titterton Lewis H jr | Director | 1 | +$131.91K | Sep 23, 2026 | |
| Titterton Lewis JR | 1 | +$7.49K | Jun 16, 2026 |
Analyst ratings on ANIX
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| D. Boral Capital | Raises | buy | $10 | +5.7% | +27.1% | Read |
Frequently asked questions
Are ANIX insiders buying or selling?
Over the last 12 months 5 insiders made 6 open-market purchases worth $240.77K and 0 insiders made 0 open-market sales worth $0, a net +$240.77K.
What is the latest insider trade in ANIX?
Catelani Michael, President, COO, & CFO filed a buy (open-market buy) of 5.50K sh worth $15.62K on Sep 30, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.